Materials and methods We examined the occurrence of pathogenic allelic variants c.238G>C, c.460G>A, c.626-1G>A, c.719A>G by PCR amplification and direct sequencing in 62 individuals.
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SMOC2, A SECRETED CALCIUM-BINDING PROTEIN AFFECTS CHONDROGENIC DIFFERENTIATION OF PRECURSOR CELLS AND HOMEOSTASIS OF CARTILAGE
Background SMOC2, a secreted calcium-binding protein of the BM-40/SPARC family was identified from a chondrogenic extract of articular cartilage and is increased in osteoarthritic cartilage. Previous research demonstrated that Wnt signalling needs to be carefully balanced in cartilage to ensure homeostasis. We evaluated the effect of SMOC2 on in vitro chondrogenesis and its relationship with Wnt signalling. Materials and methods Smoc2 was stably overexpressed or knocked down in ATDC5 cells cultured as micromasses. Impact of SMOC2 on chondrogenesis was evaluated by gene expression analysis of chondrogenic markers (Acan, Col2a1, Col10a1) and by Sirius red, Alcian Blue and Alizarin red staining to evaluate collagens, proteoglycans and mineralization. Femoral head caps of 6 weeks old mice were isolated and stimulated with IL-1b to induce cartilage breakdown. Influence of SMOC2 on cartilage breakdown was evaluated by co-stimulating femoral head caps with recombinant SMOC2 protein. Glycosaminoglycan release in the culture medium was measured by performing a DMMB assay. Background Previously, we described strongly increased expression of Wnt-1-induced signalling protein 1 (Wisp1) in the joint during experimental osteoarthritis (OA). Overexpression of Wisp1 using adenoviruses was detrimental to the articular cartilage, while decreased cartilage degeneration was observed after induction of experimental OA models in Wisp1-deficient mice. These data indicate a direct correlation between WISP1 and OA in mice. In this study we set out to characterise the relation between expression of WISP1 and human OA. Methods Articular cartilage from non-OA-diagnosed individuals with femoral neck fractures and preserved and degenerated cartilage from end-stage OA patients was collected. Degeneration was classified using the Mankin scoring system. RNA and DNA were isolated for gene expression and methylation profiles, respectively. Correlation between WISP1 expression and methylation was investigated with Generalised Linear Mixed Model (GLMM). RNA expression was determined with microarray analysis and RNA sequencing. WISP1 protein was visualised using immunohistochemistry. Effects of increased WISP1 levels were tested in a human in vitro chondrogenesis model. Results WISP1 expression in the cartilage of OA patients was increased compared to non-OA-diagnosed controls. Within OA patients, WISP1 was increased in OA-affected cartilage compared to preserved regions. WISP1 expression strongly correlated with the Mankin score. When added to cartilage particles from primary articular chondrocytes, WISP1 strongly decreased the pellet circumference and proteoglycan content. Next, we found that WISP1 expression was inversely correlated with the methylation of a positional CpG dinucleotide.
Concordantly, within donors, cartilage from OA-affected areas showed hypomethylation for this CpG site compared to preserved cartilage, which correlated with increased RNA expression. This raised the question whether individuals with high WISP1 expression were at increased risk to develop OA. Methylation of the CpG dinucleotide associated with WISP1 expression was found to be controlled by a single nucleotide polymorphism (SNP) . Surprisingly, the allele associated with higher methylation and thus lower expression of WISP1, was associated with OA. Conclusions Increased WISP1 expression in OA-affected cartilage is associated with cartilage degradation, but low WISP1 expression seems to predispose for OA-induction. Together, our results suggest that tight regulation of WISP1 expression is essential to maintain cartilage homeostasis.
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CONTRIBUTION OF MTHFR GENE POLYMORPHISMS IN PRIMARY SJÖGREN'S SYNDROME RELATED LYMPHOMAGENESIS
Background Among systemic autoimmune disorders, primary Sjogren's syndrome (pSS) has the highest risk for non-Hodgkin lymphoma (NHL) development. Two common polymorphisms, the C677T and A1298C, of the methylene-tetrahydrofolate reductase (MTHFR) gene, an enzyme essential in DNA synthesis, repair and methylation, have been reported to influence susceptibility to both autoimmune diseases and NHL. The aim of this study was to investigate the possible contribution of MTHFR variants in pSS-related lymphomagenesis. Materials and methods 262 pSS patients without NHL (pSS), 94 pSS patients with NHL [pSS-lymphoma, of which 75 had mucosa-associated lymphoid tissue (MALT) and 19 non-MALT] as well as 600 healthy controls (HC) of similar age and sex distribution were genotyped by PCR-based assays for the detection of the MTHFR gene polymorphisms (C677T and A1298C). To further evaluate the functional consequences of MTHFR variants, global DNA methylation levels were assessed by bisulphite pyrosequencing of the LINE-1 retroelement promoter in genomic DNA derived from 55 salivary gland tissues from pSS patients. Additionally, DNA double strand breaks -a marker of intrinsic DNA damage as a result of defective DNA repair-were determined in peripheral blood mononuclear cells isolated from 13 pSS patients, using comet assay. Conclusions The current report supports the contribution of MTHFR genetic variants in non-MALT NHL development in the setting of pSS, possibly through defective DNA methylation and repair mechanisms.
